Filament Health Valuation

FLHLF Stock  USD 0.04  0.0006  1.52%   
Filament Health seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of Filament Health Corp from reviewing the firm fundamentals such as Shares Outstanding of 174.95 M, operating margin of (31.94) %, and Shares Owned By Insiders of 66.23 % as well as analyzing its technical indicators and probability of bankruptcy. . In general, most investors advise locking in undervalued instruments and disposing overvalued instruments since, at some point, asset prices and their ongoing real values will submerge.
Overvalued
Today
0.04
Please note that Filament Health's price fluctuation is out of control at this time. Calculation of the real value of Filament Health Corp is based on 3 months time horizon. Increasing Filament Health's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Filament otc stock is determined by what a typical buyer is willing to pay for full or partial control of Filament Health Corp. Since Filament Health is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Filament OTC Stock. However, Filament Health's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.04 Real  0.0317 Hype  0.04 Naive  0.0449
The real value of Filament OTC Stock, also known as its intrinsic value, is the underlying worth of Filament Health Corp OTC Stock, which is reflected in its stock price. It is based on Filament Health's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Filament Health's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.03
Real Value
16.06
Upside
Estimating the potential upside or downside of Filament Health Corp helps investors to forecast how Filament otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Filament Health more accurately as focusing exclusively on Filament Health's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.030.040.04
Details
Hype
Prediction
LowEstimatedHigh
0.000.0416.07
Details
Naive
Forecast
LowNext ValueHigh
0.00090.0416.08
Details

Filament Health Total Value Analysis

Filament Health Corp is currently expected to have takeover price of 7.57 M with market capitalization of 8.08 M, debt of 868.91 K, and cash on hands of 3 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Filament Health fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
7.57 M
8.08 M
868.91 K
M

Filament Health Asset Utilization

One of the ways to look at asset utilization of Filament is to check how much profit was generated for every dollar of assets it reports. Filament Health Corp shows a negative utilization of assets of -0.21 percent, losing $0.002133 for each dollar of assets held by the firm. Inadequate asset utilization denotes the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Filament Health Corp shows how discouraging it operates for each dollar spent on its assets.

Filament Health Ownership Allocation

Filament Health holds a total of 174.95 Million outstanding shares. Filament Health Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.23 percent of Filament Health Corp outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Filament Health Profitability Analysis

Net Loss for the year was (9.25 M) with profit before overhead, payroll, taxes, and interest of 0.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Filament Health's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Filament Health and how it compares across the competition.

About Filament Health Valuation

The otc valuation mechanism determines Filament Health's current worth on a weekly basis. Our valuation model uses a comparative analysis of Filament Health. We calculate exposure to Filament Health's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Filament Health's related companies.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. Filament Health is traded on OTC Exchange in the United States.

8 Steps to conduct Filament Health's Valuation Analysis

OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Filament Health's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Filament Health's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Filament Health's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Filament Health's revenue streams: Identify Filament Health's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Filament Health's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Filament Health's growth potential: Evaluate Filament Health's management, business model, and growth potential.
  • Determine Filament Health's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Filament Health's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the otc stock being valued. We also recomment to seek professional assistance to ensure accuracy.

Filament Health Growth Indicators

Investing in growth stocks can be very risky. If the company such as Filament Health does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares Outstanding164.8 M
Retained Earnings-9.4 M

Complementary Tools for Filament OTC Stock analysis

When running Filament Health's price analysis, check to measure Filament Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Filament Health is operating at the current time. Most of Filament Health's value examination focuses on studying past and present price action to predict the probability of Filament Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Filament Health's price. Additionally, you may evaluate how the addition of Filament Health to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.